COYA vs RHI · rev $7.9M vs P/E 21, rev $5.38B
Coya Therapeutics, Inc. Common Stock (COYA) versus Robert Half International Inc (RHI) — a side-by-side from cached financials, not a winner call.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
Robert Half International Inc (RHI) is a staffing & employment services company listed on US.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
Latest reported RHI revenue for 2025-12-31 was $5.38B. Net income was $133.0M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
COYA currently screens at market cap $118.0M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
Not investment advice. Open the COYA and RHI stock pages for the full models.
Not investment advice.